Table 3.
NWC/HHcy (–) | NWC/HHcy (+) | HWC/HHcy (–) | HWC/HHcy (+) | ||
---|---|---|---|---|---|
(n = 897, 24.4%) | (n = 599, 16.3%) | (n = 1,305, 35.5%) | (n = 874, 23.8%) | ||
High FG | Model 1 | 1.00 | 0.80 (0.63, 1.01) | 2.04 (1.70, 2.45) | 1.71 (1.40, 2.09) |
Model 2 | 1.00 | 0.89 (0.72, 1.10) | 2.20 (1.85, 2.61) | 1.73 (1.42, 2.10) | |
Model 3 | 1.00 | 088 (0.66, 1.16) | 2.01 (1.62, 2.49) | 1.92 (1.51, 2.45) | |
High TG | Model 1 | 1.00 | 1.04 (0.81, 1.34) | 2.48 (2.04, 3.01) | 2.38 (1.93, 2.93) |
Model 2 | 1.00 | 0.95 (0.77, 1.17) | 1.97 (1.66, 2.34) | 2.00 (1.65, 2.42) | |
Model 3 | 1.00 | 1.32 (1.01, 1.74) | 2.50 (2.02, 3.09) | 2.74 (2.17, 3.47) | |
Low HDL—C | Model 1 | 1.00 | 1.20 (0.90, 1.61) | 2.66 (2.12, 3.33) | 2.49 (1.95, 3.18) |
Model 2 | 1.00 | 1.18 (0.93, 1.51) | 2.05 (1.68, 2.49) | 2.05 (1.64, 2.55) | |
Model 3 | 1.00 | 1.64 (1.18, 2.27) | 2.14 (1.67, 2.74) | 2.44 (1.85, 3.23) | |
High BP | Model 1 | 1.00 | 1.24 (0.98, 1.57) | 1.66 (1.36, 2.02) | 2.40 (1.89, 3.03) |
Model 2 | 1.00 | 1.27 (1.03, 1.56) | 2.06 (1.70, 2.50) | 3.39 (2.62, 4.38) | |
Model 3 | 1.00 | 1.09 (0.84, 1.41) | 1.61 (1.30, 2.00) | 2.33 (1.79, 3.05) | |
MetS | Model 1 | 1.00 | 1.11 (0.86, 1.43) | 11.52 (9.43, 14.06) | 10.47 (8.41, 13.03) |
Model 2 | 1.00 | 1.16 (0.84, 1.59) | 13.26 (10.47, 16.79) | 12.34 (9.63, 15.82) | |
Model 3 | 1.00 | 1.47 (1.04, 2.09) | 13.48 (10.37, 17.52) | 15.02 (11.28, 20.00) |
NWC, normal WC (<90 cm for men and <80 cm for women); HWC, higher WC (≥90 cm for men and ≥80 cm for women); HHcy (–): without HHcy; HHcy (+): with HHcy.
NWC/HHcy (–) group used as reference. *P <0.05.
Model 1: Unadjusted.
Model 2: Data adjusted for age.
Model 3: Data adjusted for age, sex, current smoking, current drinking, activity, hypolycemia therapy, lipid-lowering therapy, and creatinine.
WC, waist circumference; HHcy, hyperhomocysteinamia; FG, fast plasma glucose; TG, triglycerides; HDL, high–density lipoprotein cholesterol; BP, blood pressure; MetS: metabolic syndrome; OR, odds ratio.